Cleared Traditional

K251240 - Branchor X Balloon Guide Catheter

K251240 is the FDA 510(k) clearance for Branchor X Balloon Guide Catheter by Asahi Intecc Co., Ltd.. It is a Class 2 Neurology device (product code QJP) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K251240 · Asahi Intecc Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
59d
Days
Class 2
Risk

K251240 is an FDA 510(k) clearance for the Branchor X Balloon Guide Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Seto, JP). The FDA issued a Cleared decision on June 20, 2025 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Asahi Intecc Co., Ltd. devices

Submission Details

510(k) Number K251240 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2025
Decision Date June 20, 2025
Days to Decision 59 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 148d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Asahi Intecc USA, Inc.
Esther Kim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K251240.
VersaD Delivery Catheter
K251372 · Unity Medical, Inc. · Oct 2025
Carrier XL Delivery Catheter
K252569 · Balt USA, LLC · Oct 2025
DUO Microcatheter
K250960 · Rev Neuro, LLC · Sep 2025
FUBUKI XF-R Neurovascular Long Sheath
K251560 · Asahi Intecc Co., Ltd. · Jun 2025
93 NeuFlex Catheter
K251044 · Piraeus Medical · May 2025
PATH BGC
K242392 · Crossroads Neurovascular, Inc. · May 2025